12:03 AM
kotesh
Shares in Qiagen rose more than 5 percent on Friday as traders cited market talk that French drug specialist Sanofi-Aventis was considering a bid for the German Biotech. "I've heard talk of a bid of 14.50 euros per share for Qiagen," a Frankfurt-based trader says. A spokesman at Sanofi-Aventis said the company does not comment on market rumours.
